BAXTER INTERNATIONAL INC (1BAX.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1BAX - US0718131099 - Common Stock
1BAX.MI Key Statistics, Chart & Performance
The current stock price of 1BAX.MI is 30.905 EUR.
1BAX.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.94 | 112.53B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.19 | 111.98B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.71 | 47.75B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.07 | 22.91B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.3 | 22.60B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.84 | 22.57B | ||
| BIM.PA | BIOMERIEUX | 28.34 | 12.95B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 155.32 | 4.67B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.15 | 4.00B | ||
| DIA.MI | DIASORIN SPA | 18.33 | 3.40B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.79 | 1.31B | ||
| DRW8.DE | DRAEGERWERK AG | 9.61 | 1.16B |
Related stock screener links
About 1BAX.MI
Company Profile
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 38,000 full-time employees. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. The company provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Company Info
BAXTER INTERNATIONAL INC
1 Baxter Parkway,
Deerfield ILLINOIS US
Employees: 60000
Phone: 18442945418
BAXTER INTERNATIONAL INC / 1BAX.MI FAQ
What does BAXTER INTERNATIONAL INC do?
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 38,000 full-time employees. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. The company provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
What is the current price of 1BAX stock?
The current stock price of 1BAX.MI is 30.905 EUR. The price increased by 0.57% in the last trading session.
Does 1BAX stock pay dividends?
BAXTER INTERNATIONAL INC (1BAX.MI) has a dividend yield of 2.17%. The yearly dividend amount is currently 1.05.
What is the ChartMill technical and fundamental rating of 1BAX stock?
1BAX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of 1BAX stock?
BAXTER INTERNATIONAL INC (1BAX.MI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the Price/Earnings (PE) ratio of BAXTER INTERNATIONAL INC (1BAX.MI)?
The PE ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 12.61. This is based on the reported non-GAAP earnings per share of 2.45 and the current share price of 30.905 EUR.
1BAX.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1BAX.MI.
1BAX.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1BAX.MI. 1BAX.MI may be in some trouble as it scores bad on both profitability and health.
1BAX.MI Financial Highlights
Over the last trailing twelve months 1BAX.MI reported a non-GAAP Earnings per Share(EPS) of 2.45. The EPS increased by 0.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.52% | ||
| ROE | -9.32% | ||
| Debt/Equity | 1.79 |
1BAX.MI Forecast & Estimates
22 analysts have analysed 1BAX.MI and the average price target is 35.44 EUR. This implies a price increase of 14.66% is expected in the next year compared to the current price of 30.905.
For the next year, analysts expect an EPS growth of -7.17% and a revenue growth 6.13% for 1BAX.MI